Get the Ricochet app
Ricochet will work fine in a browser on your mobile devices, but for the best experience please download our app.

3 Whisky Happy Hour
The Ricochet Podcast
GLoP Culture
Beyond the Polls with Henry Olsen
Parsing Immigration Policy
Federalist Radio Hour
What the Hell Is Going On
Freedom to Learn
Daily Signal
The Erick Erickson Show
Chicks on The Right
3 Martini Lunch
The Learning Curve
The Conservative Woman’s Guide
Heritage Explains
Not Dead Yet
Giving Ventures
Who Funds that?
The Radio Free Hillsdale Hour
The Glenn Show
Call Me Back - with Dan Senor
Hillsdale Dialogues
Law Talk with Epstein, Yoo & Cooke
The Libertarian
The Report Card with Nat Malkus
The Kevin Roberts Show with Larry O’Connor
The American Idea
Madison’s Notes
Conservative Crossroads with Henry Olsen
Mom Wars
The Back of the Book
Gray Matters
Martini Shot
The Dave Carter Show
The Powerline Show
In Dissent
Heard at Heritage
Smart Girl Politics
James Lileks’ The Diner
Case in Point: The Legal Show on the Hottest Legal Cases in Politics and Culture
JobMakers
One on One with Robert Doar
Homeschooling Journeys with Curious MikeRicochet will work fine in a browser on your mobile devices, but for the best experience please download our app.
Tired of the toxicity of social media? Why not join Ricochet for just $5/month? Think of it as an online bar. Come in, have a drink, hang out, say whatever you want. But don’t badger, bully, or berate the other drinkers. That's our only rule.
Hubwonk host Joe Selvaggi talks with Pioneer Institute’s Dr. Bill Smith about his recently released paper entitled, "340B Drug Discounts, An Increasingly Dysfunctional Federal Program," which analyzes the evolution of a well-intentioned program to offer discounted drugs to the uninsured from a benefit that had helped charitable hospitals to one that has exploded to generate billions in profits while serving fewer uninsured.
Guest:
William S. Smith is Senior Fellow and Director of the Life Sciences Initiative at Pioneer Institute. He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He earned his PhD with distinction at The Catholic University of America (CUA).